: The past two decades have witnessed telemedicine becoming a crucial part of health care as a method to facilitate doctor-patient interaction. Due to technological developments and the incremental acquisition of experience in its use, telemedicine's advantages and cost-effectiveness has led to it being recognised as specifically relevant to diabetology. However, the pandemic created new challenges for healthcare systems and the rate of development of digital services started to grow exponentially. It was soon discovered that COVID-19-infected patients with diabetes had an increased risk of both mortality and debilitating sequelae. In addition, it was observed that this higher risk could be attenuated primarily by maintaining optimal control of the patient's glucose metabolism. As opportunities for actual physical doctor-patient visits became restricted, telemedicine provided the most convenient opportunity to communicate with patients and maintain delivery of care. The wide range of experiences of health care provision during the pandemic has led to the development of several excellent strategies regarding the applicability of telemedicine across the whole spectrum of diabetes care. The continuation of these strategies is likely to benefit clinical practice even after the pandemic crisis is over.

Rosta, L., Menyhart, A., Mahmeed, W.A., Al-Rasadi, K., Al-Alawi, K., Banach, M., et al. (2023). Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. FRONTIERS IN ENDOCRINOLOGY, 14, 1129793 [10.3389/fendo.2023.1129793].

Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement

Firenze, Alberto;Galia, Massimo;Rizzo, Manfredi
2023-01-01

Abstract

: The past two decades have witnessed telemedicine becoming a crucial part of health care as a method to facilitate doctor-patient interaction. Due to technological developments and the incremental acquisition of experience in its use, telemedicine's advantages and cost-effectiveness has led to it being recognised as specifically relevant to diabetology. However, the pandemic created new challenges for healthcare systems and the rate of development of digital services started to grow exponentially. It was soon discovered that COVID-19-infected patients with diabetes had an increased risk of both mortality and debilitating sequelae. In addition, it was observed that this higher risk could be attenuated primarily by maintaining optimal control of the patient's glucose metabolism. As opportunities for actual physical doctor-patient visits became restricted, telemedicine provided the most convenient opportunity to communicate with patients and maintain delivery of care. The wide range of experiences of health care provision during the pandemic has led to the development of several excellent strategies regarding the applicability of telemedicine across the whole spectrum of diabetes care. The continuation of these strategies is likely to benefit clinical practice even after the pandemic crisis is over.
2023
Rosta, L., Menyhart, A., Mahmeed, W.A., Al-Rasadi, K., Al-Alawi, K., Banach, M., et al. (2023). Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement. FRONTIERS IN ENDOCRINOLOGY, 14, 1129793 [10.3389/fendo.2023.1129793].
File in questo prodotto:
File Dimensione Formato  
2023 Front. Endocrinol.pdf

accesso aperto

Tipologia: Versione Editoriale
Dimensione 528.55 kB
Formato Adobe PDF
528.55 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/620505
Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact